Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03780868
Other study ID # Ebsar ophthalmic Center
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2012
Est. completion date July 31, 2014

Study information

Verified date December 2018
Source Menoufia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

While external DCR is the gold standard procedure for primary NLDO as well as complicated cases, SI with MMC could achieve comparable success rates in primary acquired NLDO, hence should be considered as an alternative as a safe and minimally invasive procedure.


Description:

Purpose: To compare external dacryocystorhinostomy versus canalicular silicone intubation with the use of Mitomycin C (MMC) in primary acquired nasolacrimal duct obstruction (NLDO).

Methods: the study was carried out at the department of Ophthalmology, Menoufia university Hospital, Egypt, between June 2012 to July 2014. Fifty-six patients who were diagnosed with primary acquired NLDO. Patients were randomly allocated into two groups: thirty cases underwent external DCR and twenty-six cases underwent silicone intubation with MMC.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date July 31, 2014
Est. primary completion date July 1, 2014
Accepts healthy volunteers No
Gender All
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria:

- primary acquired NLDO

Exclusion Criteria:

- All other secondary causes of NLDO

Study Design


Related Conditions & MeSH terms

  • Primary Acquired Nasolacrimal Duct Obstruction

Intervention

Procedure:
external dacryocystorhinostomy
external DCR under general anesthesia with standard sterilization procedures.
canalicular silicone intubation with MMC
canalicular silicone intubation with MMC under general anesthesia with standard sterilization procedures.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Menoufia University

Outcome

Type Measure Description Time frame Safety issue
Other canalicular silicone intubation with MMC patency of lacrimal passage was tested by height of tear meniscus and lacrimal syringing. On the basis of subjective and objective evaluation, patients were categorized into three groups: successful surgery (asymptomatic, normal tear meniscus and patent lacrimal system with syringing procedure), improvement (watery eye and/or discharge, moderate tear meniscus and partially patent lacrimal system with syringing procedure with mild regurgitation from the puncta) and failed surgery (watery eye and/or discharge, high tear meniscus and non-patent lacrimal system). 2 years
Primary external DCR patency of lacrimal passage was tested by height of tear meniscus and lacrimal syringing. On the basis of subjective and objective evaluation, patients were categorized into three groups: successful surgery (asymptomatic, normal tear meniscus and patent lacrimal system with syringing procedure), improvement (watery eye and/or discharge, moderate tear meniscus and partially patent lacrimal system with syringing procedure with mild regurgitation from the puncta) and failed surgery (watery eye and/or discharge, high tear meniscus and non-patent lacrimal system). 2 years